Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts  Masanori Niimi, MD, PhD, Nozomu Shirasugi, MD, Yosifumi Ikeda,

Slides:



Advertisements
Similar presentations
Heather J. Symons, Moshe Y
Advertisements

David D. Yuh, MD, Kimberly L. Gandy, MD, Bruce A
The Fifth Epidermal Growth Factor–like Region of Thrombomodulin Alleviates Murine Graft-versus-Host Disease in a G-Protein Coupled Receptor 15 Dependent.
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Volume 78, Issue 11, Pages (December 2010)
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell.
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
by Dennis Adeegbe, Robert B. Levy, and Thomas R. Malek
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone.
Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor–Alpha Production in Mice after.
Regulating the Immune Response to Transplants
Volume 44, Issue 6, Pages (June 2006)
Respiratory Virus-Induced Dysregulation of T-Regulatory Cells Leads to Chronic Rejection  Ankit Bharat, MD, Elbert Kuo, MD, Deepti Saini, PhD, Nancy Steward,
Antigen-Specific Peripheral Tolerance Induced by Topical Application of NF-κB Decoy Oligodeoxynucleotide  Iwao Isomura, Kunio Tsujimura, Akimichi Morita 
Thoracoscopic esophagectomy combined with mediastinoscopy via the neck
Creation of Chimeric Hearts: A Tool for Testing the “Passenger Leukocyte” Hypothesis  Simon D Eiref, Wei Zhang, Sicco H Popma, Lisa J Shah, Jonni S Moore,
Γδ T Cells Augment Rejection of Skin Grafts by Enhancing Cross-Priming of CD8 T Cells to Skin-Derived Antigen  Azad Rahimpour, Stephen R. Mattarollo,
FTY720 Markedly Increases Alloengraftment but Does Not Eliminate Host Anti-Donor T Cells that Cause Graft Rejection on Its Withdrawal  Patricia A. Taylor,
CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia.
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Xinchun Chen, Yi Zeng, Gang Li, Nicolas Larmonier, Michael W
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd  Bettina P. Iliopoulou, PhD, Katie Hsu, MS, Antonio Pierini, MD, Gordon J. Freeman,
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 18, Issue 3, Pages (March 2003)
Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune Response  Andrea T. Badillo, Kirstin J. Beggs, Elisabeth.
T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient.
Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery  John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry  Yoshifumi Ikeda, MD, Masanori Niimi, MD, PhD, Shigenao Kan,
Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine  Margaret L Schwarze, MD, Matthew T Menard, MD, Yasushi.
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
B7.2−/− Mature Dendritic Cells Generate T-Helper 2 and Regulatory T Donor Cells in Fetal Mice after In Utero Allogeneic Bone Marrow Transplantation  Swati.
Volume 29, Issue 6, Pages (December 2008)
Regulating the Immune Response to Transplants
Volume 11, Issue 2, Pages (August 1999)
Volume 21, Issue 1, Pages (January 2013)
Volume 8, Issue 5, Pages (May 2017)
Volume 19, Issue 4, Pages (October 2003)
Volume 19, Issue 3, Pages (September 2003)
Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells  Christian Scheffold, Yolanda C. Scheffold,
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Volume 5, Issue 3, Pages (September 1996)
Volume 119, Issue 1, Pages (July 2000)
Transcutaneous Gene Gun Delivery of hNC16A Induces BPAG2-Specific Tolerance  Monika Ettinger, Doris Peckl-Schmid, Christina Gruber, Martin Laimer, Josef.
Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation:
Volume 29, Issue 4, Pages (October 2008)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either.
Long-term survival of cardiac xenografts in fully xenogeneic (mouse → rat) bone marrow chimeras  Muhammad M Mohiuddin, MD, Yong Qin, MD, Xiaohua Qian,
Jennifer K. Broom, Andrew M. Lew, Hiroaki Azukizawa, Tony J
Interleukin-6 and “complex” cardiac myxoma
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
James S Allan, Joseph K Choo, Liana Vesga, J
Long-term survival of human spermatogonial stem cells in mouse testes
NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease  Wonyoung Kim, Juyang.
The future of cardiac surgery training: A survival guide
Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells  Takeshi Yokoyama,
Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production  Monika Majewska-Szczepanik, PhD,
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
Volume 23, Issue 4, Pages (October 2005)
Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery  David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,
Presentation transcript:

Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts  Masanori Niimi, MD, PhD, Nozomu Shirasugi, MD, Yosifumi Ikeda, MD, Shigenao Kan, MD, Hiroshi Takami, MD, Kimikazu Hamano, MD, PhD  The Annals of Thoracic Surgery  Volume 72, Issue 3, Pages 735-739 (September 2001) DOI: 10.1016/S0003-4975(01)02887-9

Fig 1 Depletion and recovery of CD4+ cells in the spleen after injection of anti-CD4. CBA mice were treated with depleting anti-CD4 monoclonal antibody (YTA3.1) (50 μg/dose) on two consecutive days. CD4+ cells in the spleen were counted by fluorescence activated cell sorter. Percentage of CD4+ cells compared to the original number was presented by mean ± standard deviation. The Annals of Thoracic Surgery 2001 72, 735-739DOI: (10.1016/S0003-4975(01)02887-9)

Fig 2 Operational tolerance was induced after pretreatment with donor-specific blood transfusion (DST) plus anti-CD4. CBA mice were pretreated with anti-CD4 (50 μg/dose) in combination with 0.25 mL of donor-specific blood transfusion 4 weeks before transplantation of a C57BL/10 cardiac graft. The recipients accepted the graft indefinitely in their abdomen. Second C57BL/10 or Balb/c cardiac grafts were transplanted into the neck of the recipients 100 days after the first transplantation. ∗p < 0.001 between the two groups. (MST = median survival time.) The Annals of Thoracic Surgery 2001 72, 735-739DOI: (10.1016/S0003-4975(01)02887-9)

Fig 3 Regulatory cells were generated 100 days after transplantation in the mice pretreated with donor-specific blood transfusion (DST) plus anti-CD4. CBA mice were pretreated with anti-CD4 (50 μg/dose) in combination with 0.25 mL of donor-specific blood transfusion 4 weeks before transplantation of a C57BL/10 cardiac graft. The recipients accepted their graft indefinitely. Splenocytes (5 × 107) from the recipient or naive mice were adoptively transferred into the naive CBA mice. C57BL/10 cardiac grafts were transplanted into the second recipient 1 day after the adoptive transfer. ∗p less than 0.001 between the two groups. (MST = median survival time.) The Annals of Thoracic Surgery 2001 72, 735-739DOI: (10.1016/S0003-4975(01)02887-9)

Fig 4 C57BL/10 splenocytes (1 × 107) were stained with carboxyfluorescein succinimidyl ester (CFSE) before injection and injected intravenously into CBA mice. Spleens and thymus were sampled and fluorescence-positive cells were counted by fluorescence activated cell sorter. Data were presented as the mean of three mouse samples ± standard deviation and are representative of four independent experiments. The Annals of Thoracic Surgery 2001 72, 735-739DOI: (10.1016/S0003-4975(01)02887-9)